After receiving an injection, some people experience symptoms at the injection site on the skin. This reaction is a common adverse effect of vaccines, Botox injections, biologics, and chemotherapy.
A US Food and Drug Administration (FDA) investigation of injection-site necrosis in some people who received the 23-valent pneumococcal vaccine has concluded that the benefits of the vaccine outweigh ...
PDUFA date set for February 7, 2025 If approved by the FDA, label would expand to include alternative injection sites in the thigh, buttock and back of the arm for induction and maintenance as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback